Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients

NCT06303089 | Completed DMC

• 1 other identifier: zzwee-quit (CKD) 23152
• Study Type: observational
• Target: 567
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to describe the tobacco exposure and characteristics of patients with Chronic Kidney Disease (CKD) who quit smoking, to identify patients' tobacco-related knowledge, attitude, and practice (KAP) and explore the influencing factors of smoking cessation.

Conditions

Smoking Cessation

Keywords

Chronic kidney disease; Smoking cessation behavior; Cross-sectional study; Tobacco-related knowledge, attitudes, and practice; Tobacco exposure

Outcome Measures

Primary Outcomes (2)

• Prevalence of current smokers

  A true or false sheet in the questionnaire.

  Baseline

• Abstinence rates

  A true or false sheet in the questionnaire.

  Baseline

Secondary Outcomes (6)

• Nicotine dependence

  Baseline

• Perceptions of tobacco harm

  Baseline

• knowledge of tobacco-related diseases

  Baseline

• Smoking related attitudes

  Baseline

• Self-efficacy level

  Baseline

Study Arms (1)

Questionnaires assessed Chronic Kidney Disease patients

Participants who met the inclusion criteria below will be invited to fill in tobacco exposure questionnaires, smokers will be invited to complete smoking cessation questionnaires set. 1. Participants aged 18 years or older; 2. Participants with a confirmed diagnosis of Chronic Kidney Disease;

Other: Questionnaires set

Interventions

Questionnaires set OTHER

Participants will be asked to respond to the demographic information sheet, characteristics of smoking sheet, tobacco-related knowledge, perceptions of tobacco harm. Smokers will be asked the history of smoking cessation sheet, the Fagerstrom Test of Nicotine Dependence, Smoking Self-efficacy Questionnaire, Cigarette Withdrawal Scale, Intention to Quit Smoking sheet, Motivation to Quit Smoking sheet, Alcohol Use Disorders Identification Test, and International Physical Activity Questionnaire.

Questionnaires assessed Chronic Kidney Disease patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Chronic Kidney Disease Patients

You may qualify if:

• Participants aged 18 years or older;
• Participants with a confirmed diagnosis of Chronic Kidney Disease;
• Participants were able to speak and read Chinese.;

You may not qualify if:

• Participants who with psychiatric illness, disorders of consciousness, communication impairments, were unable to communicate effectively;
• Participants who have acute and life-threatening exacerbations which require urgent treatment;
• Patients who currently involved in other smoking cessation programs.

Sponsors & Collaborators

• Sun Yat-sen University: lead

Study Sites (1)

XIAW

Guangzhou, Guangdong, 510080, China

Location

MeSH Terms

Conditions

Smoking Cessation; Renal Insufficiency, Chronic; Behavior

Condition Hierarchy (Ancestors)

Health Behavior; Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Wei Xia, PhD

  Sun Yat-sen University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: A.P.

Study Record Dates

• First Submitted: March 4, 2024
• First Posted: March 12, 2024
• Study Start: April 5, 2024
• Primary Completion: January 31, 2025
• Study Completion: April 15, 2025
• Last Updated: April 23, 2025

Record last verified: 2025-04

Data Sharing

• IPD Sharing: Will share
• Shared Documents: SAP
• Time Frame: After the publication of the study
• Access Criteria: Researchers should contact the PI for approval of the study protocol.

Locations

CN (1)